Advertisement

Breast Implant–Associated Anaplastic Large Cell Lymphoma

      Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare type of lymphoma that is most commonly associated with textured breast implants.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Keech J.A.
        • Creech B.
        Anaplastic T-cell lymphoma in proximity to a saline filled breast implant.
        Plast Reconstr Surg. 1997; 100: 554-555
        • Swerdlow S.H.
        • Campo E.
        • Pileri S.A.
        • et al.
        The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
        Blood. 2016; 127: 2375-2390
      1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). T-Cell Lymphomas, Version 1.2021-October 5, 2020.
        (Available at:) (Accessed November 23, 2020)
        • Leberfinger A.N.
        • Behar B.J.
        • Williams N.C.
        • et al.
        Breast implant-associated anaplastic large cell lymphoma – A systematic review.
        JAMA Surg. 2017; 152: 1161-1168
        • Collett D.J.
        • Rakhorst H.
        • Lennox P.
        • et al.
        Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants.
        Plast Reconstr Surg. 2019; 143: 30S-40S
        • Doren E.L.
        • Miranda R.N.
        • Selber J.C.
        U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma.
        Plast Reconstr Surg. 2017; 139: 1042-1050
        • Jones J.L.
        • Hanby A.M.
        • Wells C.
        • et al.
        Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
        Histopathology. 2019; 75: 787-796
        • Oishi N.
        • Miranda R.
        • Feldman A.
        Genetics of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
        Aesthet Surg J. 2019; 39: S14-S20
        • Di Napoli A.
        • Jain P.
        • Duranti E.
        • et al.
        Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.
        Br J Hematol. 2018; 180: 735-760
        • Clemens M.W.
        • Brody G.S.
        • Mahabir R.C.
        • et al.
        How to diagnose and treat breast implant-associated anaplastic large cell lymphoma.
        Plast Reconstr Surg. 2018; 141: 586e-599e
      2. American Society of Plastic Surgeons BIA-ALCL PROFILE (Patient Registry and Outcomes for breast Implants and anaplastic large cell Lymphoma etiology and Epidemiology) registry.
        (Available at:) (Accessed November 25, 2020)
        • Clemens M.W.
        • Jacobsen E.D.
        • Horwitz S.M.
        2019 NCCN Consensus Guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
        Aesthet Surg J. 2019; 39: S3-S13
        • Collins M.S.
        • Miranda R.N.
        • Medeiros L.J.
        • et al.
        Characteristics and treatment of advanced breast implant-associated anaplastic large cell lymphoma.
        Plast Reconstr Surg. 2019; 143: 41S-50S
      3. The FDA requests allergan voluntarily recall natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients: FDA safety communications.
        (Available at:) (Accessed November 12, 2020)
      4. Breast implants – certain labeling recommendations to improve patient communication.
        (Available at:) (Accessed November 12, 2020)